Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany
Authors:
Open Access
- 1 September 2006
- journal article
- research article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 65 (9) , 1175-1183
Abstract
Objective: To estimate and compare the direct and indirect costs of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis (PsA) and systemic lupus erythematosus (SLE), and to evaluate the effect of sex, disease duration and functional status on the various cost domains. Methods: Data of outpatients, aged 18–65, with rheumatoid arthritis (n = 4351), ankylosing spondylitis (n = 827), PsA (n = 908) or SLE (n = 844), who were enrolled in the national database of the German collaborative arthritis centres in 2002, were analysed. Data on healthcare consumption, out-of-pocket expenses and productivity losses were derived from doctors and patients. For the calculation of indirect costs, the human capital approach (HCA) and the friction cost approach (FCA) were applied. Results: Mean direct costs amounted to €4737 a year in rheumatoid arthritis, €3676 in ankylosing spondylitis, €3156 in PsA and €3191 in SLE. By using the HCA, total costs were calculated at €15 637 in rheumatoid arthritis, €13 513 in ankylosing spondylitis, €11 075 in PsA and €14 411 in SLE, whereas with the FCA the numbers were €7899, €7204, €5570 and €6518, respectively. Costs increased with disease duration and were strongly dependent on functional status. In patients with the highest disability (Conclusion: The costs of illness are high in all four diseases, with a strong effect of functional status on total costs. Indirect costs differ by the factor 3, based on whether the HCA or the FCA is used.Keywords
This publication has 28 references indexed in Scilit:
- Cost effectiveness of etanercept (Enbrel) in combination with methotrexate in the treatment of active rheumatoid arthritis based on the TEMPO trialAnnals of the Rheumatic Diseases, 2005
- Indirect cost assessment in patients with rheumatoid arthritis (RA): Comparison of data from the health economic patient questionnaire HEQ‐RA and insurance claims dataArthritis Care & Research, 2005
- Rheumatoid arthritis is already expensive during the first year of the disease (the Swedish TIRA project)Rheumatology, 2004
- Determinants of direct costs in Dutch rheumatoid arthritis patientsAnnals of the Rheumatic Diseases, 2004
- Direct costs of ankylosing spondylitis and its determinants: an analysis among three European countriesAnnals of the Rheumatic Diseases, 2003
- The national database of the German Collaborative Arthritis Centres: I. Structure, aims, and patientsAnnals of the Rheumatic Diseases, 2001
- The friction cost method for measuring indirect costs of diseaseJournal of Health Economics, 1995
- Locomotion status and costs in destructive rheumatoid arthritisActa Orthopaedica, 1992
- A multicenter study of hospitalization in rheumatoid arthritis. Frequency, medical‐surgical admissions, and chargesArthritis & Rheumatism, 1986
- A multicenter study of annual health service utilization and costs in rheumatoid arthritisArthritis & Rheumatism, 1986